GOLD adherence raises costs in stage III COPD

Results of Spanish research show that adherence to the Global Initiative for Chronic Lung Disease guidelines reduces overall costs in the treatment of stage II chronic obstructive pulmonary disease, but not in stage III disease.
Source: MedWire News - Respiratory - Category: Respiratory Medicine Source Type: news